Altered reference ranges for protein C and protein S during early pregnancy: Implications for the diagnosis of protein C and protein S deficiency during pregnancy

Thrombosis and Haemostasis

Volumn 103, Issue 5, 2010, Pages 984-988

  Said, Joanne M ^a,b   Ignjatovic, Vera ^b,c   Monagle, Paul T ^b,c   Walker, Susan P ^b,d   Higgins, John R ^a,b,e   Brennecke, Shaun P ^a,b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MERCY HOSPITAL FOR WOMEN   (Australia)

^e UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antithrombin; Natural anticoagulants; Pregnancy; Protein C; Protein S; Reference ranges; Thrombophilia; Thrombosis

Indexed keywords

ANTITHROMBIN; PROTEIN C; PROTEIN S;

ARTICLE; BLOOD SAMPLING; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MATERNAL AGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; VENOUS BLOOD; ADULT; BLOOD; BLOOD CLOTTING; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REFERENCE VALUE;

ADULT; ANTITHROMBINS; BLOOD COAGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTERS; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN C DEFICIENCY; PROTEIN S; PROTEIN S DEFICIENCY; REFERENCE VALUES;

EID: 77952060000     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-07-0476     Document Type: Article

References (20)

1. O'Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003; 17: 385-396.
2. Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Repr Biol 1997; 73: 31-36. (Pubitemid 27224457)
3. Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-1170. (Pubitemid 28297166)
4. Uchikova E, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Repr Biol 2005; 119: 185-188.
5. Dekker GA, de Vries JI, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995; 173: 1042-1048.
6. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
7. Wickstrom K, Edelstam G, Lowbeer CH, et al. Reference intervals for plasma levels of fibronectin, von-Willebrand factor, free protein S, and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest 2004; 64: 31-40. (Pubitemid 38283207)
8. Bremme K, Ostlund E, Almqvist I, et al. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992; 80: 132-137.
9. Lefkowitz J, Clarke S, Barbour L. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol 1996; 175: 657-660. (Pubitemid 126689825)
10. Oruc S, Saruc M, Koyuncu FM, et al. Changes in plasma activities of protein C and protein S during pregnancy. Aust N Z J Obstet Gynaecol 2000; 40: 448-450.
11. Tait RC, Walker ID, Islam SI, et al. Influence of demographic factors on antithrombin III activity in a healthy population. Br J Haematol 1993; 84: 476-480.
12. Dykes AC, Walker ID, McMahon AD, et al. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-641.
13. Faught W, Garner P, Jones G, et al. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995; 172: 147-150.
14. Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362-372.
15. Tait RC, Walker ID, Islam SI, et al. Protein C activity in healthy volunteers - influence of age, sex, smoking and oral contraceptives. Thromb Haemost 1993; 70: 281-285.
16. Isermann B, Sood R, Pawlinski R, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nature Med 2003; 9: 331-337.
17. Weiler H. Mouse models of thrombosis: thrombomodulin. Thromb Haemost 2004; 92: 467-477.
18. Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29 (7 Suppl): S48-S52.
19. Toltl LJ, Swystun LL, Pepler L, et al. Protective effects of activated protein C in sepsis. Thromb Haemost 2008; 100: 582-592.
20. Murakami K, Okajima K, Uchiba M, et al. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol Lung Cell Mol Physiol 1997; 272: L197-202.